MO4-7 Efficacy and safety with selpercatinib in patients with RET fusion+ NSCLC: Analysis by last prior systemic therapy

Autor:	Keunchil Park, Geoffrey R. Oxnard, Filippo de Braud, Alexander Drilon, Caroline E. McCoach, Daniel Shao Weng Tan, Pearl Plernjit French, Oliver Gautschi, Benjamin Besse, G. Alonso Casal, Victoria Soldatenkova, Koichi Goto
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine medicine In patient Hematology RET Fusion business Systemic therapy
Zdroj:	Annals of Oncology. 32:S297
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.05.570
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5a0d0330e0fd2f2a451f859bc7ed76c5 https://doi.org/10.1016/j.annonc.2021.05.570 Zobrazit plný text záznamu